Although we did not analyze the data according to the severity of the disease or gestation age of presentation, our study describes major differences in the A2BAR/NO/VEGF signaling pathway when cells from preeclampsia are compared with those derived from normotensive pregnancies. This evidence concerns the gene VEGFA and preeclampsia.